vTv Therapeutics Entered Into A Sales Agreement With Cowen And Company; Pursuant To Agreement Co May Offer And Sell Shares Of Class A Common Stock Having Aggregate Offering Price Of Up To $50.0M
Portfolio Pulse from Benzinga Newsdesk
VTV Therapeutics Inc has entered into a sales agreement with Cowen and Company, allowing it to offer and sell shares of its Class A common stock up to an aggregate offering price of $50 million, according to an SEC filing.
February 28, 2024 | 2:32 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
VTV Therapeutics Inc has announced a sales agreement with Cowen and Company to sell up to $50 million of its Class A common stock.
The announcement of a sales agreement for VTV Therapeutics Inc to potentially sell up to $50 million in Class A common stock could have a neutral to slightly positive impact on its stock price. The ability to raise capital is positive, but the potential dilution of existing shares could offset some of that optimism. The exact impact will depend on investor perception of the company's need for additional capital and its plans for using the proceeds.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100